BTR Capital Management’s Core Laboratories CLB Stock Holding History

BTR Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,865	Closed	-$266K	–	171
2019 Q1	$266K	Sell	3,865 -85	-2%	-$5.7K	0.05%	142
2018 Q4	$236K	Sell	3,950 -5,155	-57%	-$445K	0.05%	147
2018 Q3	$1.05M	Sell	9,105 -200	-2%	-$22.6K	0.18%	75
2018 Q2	$1.17M	Sell	9,305 -250	-3%	-$30.4K	0.23%	69
2018 Q1	$1.03M	Sell	9,555 -75	-0.8%	-$8.3K	0.21%	72
2017 Q4	$1.05M	Sell	9,630 -75	-0.8%	-$7.49K	0.21%	75
2017 Q3	$958K	Buy	9,705 +230	+2%	+$22.3K	0.2%	74
2017 Q2	$960K	Sell	9,475 -200	-2%	-$21.6K	0.2%	74
2017 Q1	$1.12M	Buy	9,675 +1,595	+20%	+$185K	0.23%	66
2016 Q4	$908K	Hold	8,080	–	–	0.2%	72
2016 Q3	$908K	Buy	8,080 +445	+6%	+$51.3K	0.2%	72
2016 Q2	$946K	Sell	7,635 -3,260	-30%	-$394K	0.22%	75
2016 Q1	$1.23M	Sell	10,895 -715	-6%	-$74.3K	0.28%	72
2015 Q4	$1.26M	Buy	11,610 +655	+6%	+$75K	0.29%	76
2015 Q3	$1.09M	Buy	10,955 +2,570	+31%	+$280K	0.26%	80
2015 Q2	$956K	Buy	+8,385	New	+$1.02M	0.23%	76

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BTR Capital Management's CLB Position: Q2 2019 in Review

BTR Capital Management sold out of Core Laboratories (CLB) in Q2 2019, closing a stake of 3,865 shares — an estimated $266K sold.

BTR Capital Management first reported a position in CLB in Q2 2015 and held it in 16 quarters. The position peaked at $1.26M in Q4 2015. 304 funds tracked by Wall St. Rank hold CLB as of Q2 2019.

BTR Capital Management reported no remaining Core Laboratories position as of Q2 2019 after selling out during the quarter.
BTR Capital Management sold 3,865 Core Laboratories shares in Q2 2019, an estimated $266K.
BTR Capital Management first reported a position in Core Laboratories in Q2 2015 and held it in 16 quarters.
BTR Capital Management's Core Laboratories position peaked at $1.26M in Q4 2015.
304 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2019.

Based on BTR Capital Management's 13F filing for Q2 2019, filed 18 Jul 2019.